Publications
-
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.
Edris B,
Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M.
Proc Natl Acad Sci U S A.
2013;
110
(9):
3501-6
-
Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations.
Sweeney RT,
Zhang B, Zhu SX, Varma S, Smith KS, Montgomery SB, van de Rijn M, Zehnder J, West RB.
Am J Surg Pathol.
2013;
37
(6):
796-803
-
Genome Evolution during Progression to Breast Cancer.
Newburger DE,
Kashef-Haghighi D, Weng Z, Salari R, Sweeney RT, Brunner AL, Zhu SX, Guo X, Varma S, Troxell ML, West RB, Batzoglou S, Sidow A.
Genome Res.
2013
-
Human papillomavirus 16 detected in nasopharyngeal carcinomas in Caucasian Americans but not in endemic Southern Chinese patients.
Lin Z,
Khong B, Kwok S, Cao H, West RB, Le QT, Kong CS.
Head Neck.
2013
-
Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
Hollmig ST,
Rieger KE, Henderson MT, West RB, Sundram UN.
Am J Dermatopathol.
2013;
35
(2):
176-9
-
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Lee CH,
Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJ, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA.
Proc Natl Acad Sci U S A.
2012;
109
(3):
929-34
-
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma.
Edris B,
Weiskopf K, Volkmer AK, Volkmer JP, Willingham SB, Contreras-Trujillo H, Liu J, Majeti R, West RB, Fletcher JA, Beck AH, Weissman IL, van de Rijn M.
Proc Natl Acad Sci U S A.
2012;
109
(17):
6656-61
-
Biphasic papillary and lobular breast carcinoma with PIK3CA and IDH1 mutations.
Ang D,
VanSandt AM, Beadling C, Warrick A, West RB, Corless CL, Troxell ML.
Diagn Mol Pathol.
2012;
21
(4):
221-4
-
Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.
Edris B,
Fletcher JA, West RB, van de Rijn M, Beck AH.
Sarcoma.
2012:
2012
805614
-
Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma.
Chisholm KM,
Wan Y, Li R, Montgomery KD, Chang HY, West RB.
PLoS One.
2012;
7
(10):
e47998
-
Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.
Kaplan JS,
Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM.
Am J Surg Pathol.
2012;
36
(10):
1483-8
-
Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.
Troxell ML,
Brunner AL, Neff T, Warrick A, Beadling C, Montgomery K, Zhu S, Corless CL, West RB.
Mod Pathol.
2012;
25
(7):
930-7
-
ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
Edris B,
Espinosa I, Mühlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, Fletcher JA, Beck AH, West RB, Nusse R, van de Rijn M.
J Pathol.
2012;
227
(2):
223-33
-
Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR,
Nielsen TO, van de Rijn M, West RB.
Appl Immunohistochem Mol Morphol.
2012;
20
(5):
445-50
-
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
Ohgami RS,
Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA.
Am J Surg Pathol.
2012;
36
(11):
1619-28
-
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.
Brunner AL,
Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, Tibshirani R, Chang HY, van de Rijn M, West RB.
Genome Biol.
2012;
13
(8):
R75
-
β-Adrenergic receptor expression in vascular tumors.
Chisholm KM,
Chang KW, Truong MT, Kwok S, West RB, Heerema-McKenney AE.
Mod Pathol.
2012;
25
(11):
1446-51
-
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
Espinosa I,
Edris B, Lee CH, Cheng HW, Gilks CB, Wang Y, Montgomery KD, Varma S, Li R, Marinelli RJ, West RB, Nielsen T, Beck AH, van de Rijn M.
Am J Pathol.
2011;
179
(4):
2100-7
-
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.
Wu JM,
Beck AH, Pate LL, Witten D, Zhu SX, Montgomery KD, Allison KH, van de Rijn M, West RB.
Clin Cancer Res.
2011;
17
(3):
437-46
-
Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM,
Beck AH, Montgomery KD, Zhu SX, Espinosa I, Lee CH, Subramanian S, Fletcher CD, van de Rijn M, West RB.
Am J Surg Pathol.
2011;
35
(4):
583-9
-
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
Tanas MR,
Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP.
Sci Transl Med.
2011;
3
(98):
98ra82
-
Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
Sangoi AR,
Fujiwara M, West RB, Montgomery KD, Bonventre JV, Higgins JP, Rouse RV, Gokden N, McKenney JK.
Am J Surg Pathol.
2011;
35
(5):
678-86
-
Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.
Colombo C,
Creighton CJ, Ghadimi MP, Bolshakov S, Warneke CL, Zhang Y, Lusby K, Zhu S, Lazar AJ, West RB, van de Rijn M, Lev D.
J Pathol.
2011;
225
(4):
574-82
-
MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
West RB,
Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT.
Am J Surg Pathol.
2011;
35
(1):
92-9
-
Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.
Beck AH,
Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, van de Vijver MJ, West RB, van de Rijn M, Koller D.
Sci Transl Med.
2011;
3
(108):
108ra113
-
3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.
Beck AH,
Weng Z, Witten DM, Zhu S, Foley JW, Lacroute P, Smith CL, Tibshirani R, van de Rijn M, Sidow A, West RB.
PLoS One.
2010;
5
(1):
e8768
-
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M,
Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.
Breast Cancer Res Treat.
2010;
123
(2):
397-404
-
DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
Lopes LF,
West RB, Bacchi LM, van de Rijn M, Bacchi CE.
Appl Immunohistochem Mol Morphol.
2010;
18
(4):
333-7
-
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
Beck AH,
Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, Montgomery KD, Marinelli RJ, Tibshirani R, Hastie T, Jablons DM, Rubin BP, Fletcher CD, West RB, van de Rijn M.
Oncogene.
2010;
29
(6):
845-54
-
Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB,
Adv Anat Pathol.
2010;
17
(5):
366-73
-
Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.
Beck AH,
West RB, van de Rijn M.
Virchows Arch.
2010;
456
(2):
141-51
-
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
Subramanian S,
Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M.
J Pathol.
2010;
220
(1):
58-70
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
Gupta RA,
Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY.
Nature.
2010;
464
(7291):
1071-6
-
Translating gene expression into clinical care: sarcomas as a paradigm.
Nielsen TO,
West RB.
J Clin Oncol.
2010;
28
(10):
1796-805
-
Variations in stromal signatures in breast and colorectal cancer metastases.
Webster JA,
Beck AH, Sharma M, Espinosa I, Weigelt B, Schreuder M, Montgomery KD, Jensen KC, van de Rijn M, West R.
J Pathol.
2010;
222
(2):
158-65
-
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract.
Gomez-Pinilla PJ,
Gibbons SJ, Bardsley MR, Lorincz A, Pozo MJ, Pasricha PJ, Van de Rijn M, West RB, Sarr MG, Kendrick ML, Cima RR, Dozois EJ, Larson DW, Ordog T, Farrugia G.
Am J Physiol Gastrointest Liver Physiol.
2009;
296
(6):
G1370-81
-
Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
Espinosa I,
Beck AH, Lee CH, Zhu S, Montgomery KD, Marinelli RJ, Ganjoo KN, Nielsen TO, Gilks CB, West RB, van de Rijn M.
Am J Pathol.
2009;
174
(6):
2347-56
-
Expression of insulin-like growth factor 2 in mesenchymal neoplasms.
Steigen SE,
Schaeffer DF, West RB, Nielsen TO.
Mod Pathol.
2009;
22
(7):
914-21
-
External beam radiation therapy enhances local control in pigmented villonodular synovitis.
Horoschak M,
Tran PT, Bachireddy P, West RB, Mohler D, Beaulieu CF, Kapp DS, Donaldson SS.
Int J Radiat Oncol Biol Phys.
2009;
75
(1):
183-7
-
HER2 Intermediate Breast Cancers.
Jensen KC,
Nielsen TO, Gilks CB, West RB.
Am J Surg Pathol.
2009;
33
(11):
1739; author reply 1739-40
-
MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study.
Pai RK,
West RB.
Appl Immunohistochem Mol Morphol.
2009;
17
(3):
202-6
-
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C,
Higgins JP, West RB, Natkunam Y, Heerema-McKenney A, Arber DA.
Am J Surg Pathol.
2009;
33
(11):
1695-704
-
The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
Beck AH,
Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.
Clin Cancer Res.
2009;
15
(3):
778-87
-
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I,
Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML, van de Rijn M.
Am J Surg Pathol.
2008;
32
(2):
210-8
-
Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue.
Jensen KC,
Schaeffer DF, Cheang M, Montgomery K, West RB, Gilks CB, Ross D, Turashvili G, Schnitt S, van de Rijn M.
Mod Pathol.
2008;
21
(12):
1413-20
-
Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH,
Dadras SS, Goldblum JR, van de Rijn M, West RB, Rubin BP.
Am J Clin Pathol.
2008;
129
(6):
886-93
-
Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
Lee CH,
Espinosa I, Jensen KC, Subramanian S, Zhu SX, Varma S, Montgomery KD, Nielsen TO, van de Rijn M, West RB.
Mod Pathol.
2008;
21
(5):
531-9
-
Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
Huang HY,
West RB, Tzeng CC, van de Rijn M, Wang JW, Chou SC, Huang WW, Eng HL, Lin CN, Yu SC, Wu JM, Lu CC, Li CF.
Clin Cancer Res.
2008;
14
(19):
6023-32
-
KIT gene mutations and copy number in melanoma subtypes.
Beadling C,
Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL.
Clin Cancer Res.
2008;
14
(21):
6821-8
-
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up.
Jensen KC,
Turbin DA, Leung S, Miller MA, Johnson K, Norris B, Hastie T, McKinney S, Nielsen TO, Huntsman DG, Gilks CB, West RB.
Breast Cancer Res Treat.
2008;
112
(3):
453-9
-
Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH,
Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery KD, Zhu S, Marinelli RJ, Peterse JL, Poulin N, Nielsen TO, West RB, Gilks CB, van de Rijn M.
Clin Cancer Res.
2008;
14
(5):
1423-30
-
The Stanford Tissue Microarray Database.
Marinelli RJ,
Montgomery K, Liu CL, Shah NH, Prapong W, Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West RB, van de Rijn M, Brown PO, Ball CA.
Nucleic Acids Res.
2008;
36
(Database issue):
D871-7
-
The fibromatosis signature defines a robust stromal response in breast carcinoma.
Beck AH,
Espinosa I, Gilks CB, van de Rijn M, West RB.
Lab Invest.
2008;
88
(6):
591-601
-
Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis.
West RB,
van de Rijn M.
Lab Invest.
2007;
87
(10):
967-70
-
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
Lehman NL,
Tibshirani R, Hsu JY, Natkunam Y, Harris BT, West RB, Masek MA, Montgomery K, van de Rijn M, Jackson PK.
Am J Pathol.
2007;
170
(5):
1793-805
-
Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
Cupp JS,
Miller MA, Montgomery KD, Nielsen TO, O'Connell JX, Huntsman D, van de Rijn M, Gilks CB, West RB.
Am J Surg Pathol.
2007;
31
(6):
970-6
-
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
West RB,
Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M.
Proc Natl Acad Sci U S A.
2006;
103
(3):
690-5
-
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
Sneddon JB,
Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO.
Proc Natl Acad Sci U S A.
2006;
103
(40):
14842-7
-
Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus.
Troxell ML,
Bangs CD, Lawce HJ, Galperin IB, Baiyee D, West RB, Olson SB, Cherry AM.
Am J Clin Pathol.
2006;
126
(5):
709-16
-
The role of microarray technologies in the study of soft tissue tumours.
West RB,
van de Rijn M.
Histopathology.
2006;
48
(1):
22-31
-
Upregulation of histidine decarboxylase expression in superficial cortical nephrons during pregnancy in mice and women.
Morgan TK,
Montgomery K, Mason V, West RB, Wang L, van de Rijn M, Higgins JP.
Kidney Int.
2006;
70
(2):
306-14
-
Determination of stromal signatures in breast carcinoma.
West RB,
Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussard T, Goldblum JR, Brown PO, van de Vijver M, van de Rijn M.
PLoS Biol.
2005;
3
(6):
e187
-
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
Nguyen TT,
Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y.
Am J Surg Pathol.
2005;
29
(5):
617-24
-
Nuclear beta-catenin in mesenchymal tumors.
Ng TL,
Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB, Nielsen TO.
Mod Pathol.
2005;
18
(1):
68-74
-
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
Liu CL,
Montgomery KD, Natkunam Y, West RB, Nielsen TO, Cheang MC, Turbin DA, Marinelli RJ, van de Rijn M, Higgins JP.
Mod Pathol.
2005;
18
(12):
1641-8
-
The gene expression profile of extraskeletal myxoid chondrosarcoma.
Subramanian S,
West RB, Marinelli RJ, Nielsen TO, Rubin BP, Goldblum JR, Patel RM, Zhu S, Montgomery K, Ng TL, Corless CL, Heinrich MC, van de Rijn M.
J Pathol.
2005;
206
(4):
433-44
-
Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.
West RB,
Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, Montgomery K, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Brown PO, van de Rijn M, Lui CL.
Am J Surg Pathol.
2004;
28
(8):
1063-9
-
CD117 expression in mesothelioma.
Arber DA,
Weiss LM, West RB.
Mod Pathol.
2004;
17
(8):
1021
-
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.
Subramanian S,
West RB, Corless CL, Ou W, Rubin BP, Chu KM, Leung SY, Yuen ST, Zhu S, Hernandez-Boussard T, Montgomery K, Nielsen TO, Patel RM, Goldblum JR, Heinrich MC, Fletcher JA, van de Rijn M.
Oncogene.
2004;
23
(47):
7780-90
-
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.
Chang HY,
Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO.
PLoS Biol.
2004;
2
(2):
E7
-
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB,
Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M.
Am J Pathol.
2004;
165
(1):
107-13
-
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
Linn SC,
West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D, Brown PO, Gilks CB, van de Rijn M.
Am J Pathol.
2003;
163
(6):
2383-95
-
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
Nielsen TO,
Hsu FD, O'Connell JX, Gilks CB, Sorensen PH, Linn S, West RB, Liu CL, Botstein D, Brown PO, van de Rijn M.
Am J Pathol.
2003;
163
(4):
1449-56
-
Molecular characterisation of soft tissue tumours: a gene expression study.
Nielsen TO,
West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M.
Lancet.
2002;
359
(9314):
1301-7
-
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
West RB,
Warnke RA, Natkunam Y.
Am J Clin Pathol.
2002;
117
(4):
636-43
-
Antigen receptor gene rearrangement.
Grawunder U,
West RB, Lieber MR.
Curr Opin Immunol.
1998;
10
(2):
172-80
-
Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini.
West RB,
Yaneva M, Lieber MR.
Mol Cell Biol.
1998;
18
(10):
5908-20
-
The RAG-HMG1 complex enforces the 12/23 rule of V(D)J recombination specifically at the double-hairpin formation step.
West RB,
Lieber MR.
Mol Cell Biol.
1998;
18
(11):
6408-15
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help